Nucleotide in Medical Technology
Navigation Links
Nucleotide in Medical Technology
... C (HCV). PSI-7851 is a second generation nucleotide polymerase inhibitor of HCV.
PSI-7851 ... safety data with PSI-7851, our second generation nucleotide analog," said Michelle Berrey, MD, MPH, ... that we have achieved our goal of identifying a nucleotide analog with good efficacy that can be ...
... that it has initiated a proof-of-concept study of IDX184, a liver-targeted nucleotide prodrug candidate for the treatment of HCV under an Investigational New ... and two to placebo. About IDX184 IDX184 is a once-daily, oral nucleotide prodrug candidate based on Idenix's proprietary liver-targeting ....
... DNA damage measured by histone H2AX phosphorylation independently of the nucleotide excision repair pathways. (Abstract #B77) Yves Pommier, M.D., Ph.D., ... 743. In addition, the study showed brostallicin is less dependent on the nucleotide excision repair (NER) gene than ecteinascidin 743 and that cells selected ...
... 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," provides fertility specialists for the first time ... amplified, approximately 250,000 different areas of the DNA, called single nucleotide polymorphisms (SNPs, or "snips") are individually examined and assigned a ...
... data set from this study at a scientific meeting later this year. About IDX184 IDX184 is a novel, liver-targeted 2'-methyl guanosine nucleotide prodrug, which includes Idenix's proprietary liver-targeting technology. This technology enables the delivery of nucleoside monophosphate to the ...
... a rapid, accurate, and cost efficient manner. SEQUENOM's MassARRAY system facilitates a number of nucleic acid analysis applications including single nucleotide polymorphism (SNP) genotyping and allelotyping, copy number variation analysis, quantitative gene expression analysis, quantitative methylation ...
... of HIV in combination with other approved HIV drugs, has completed a Phase II clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered Phase I studies. Additional information is available on the Internet at http://www.pharmasset.com ...
... of HIV in combination with other approved HIV drugs, has completed a Phase II clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered Phase I studies. Pharmasset Forward-Looking Statements Pharmasset "Safe Harbor" Statement under the Private ...
... found Korean women in the study were seventy percent more likely to get vertebral fracture if they carried a genetic variation, also called single nucleotide polymorphism (SNP), in the IL-10 gene, while those who carried a SNP in the IL1-RN gene were fifty percent more predisposed to vertebral fracture. ...
... and detect the most significant gene variants associated with a given disease. Those variants, each a change in a single DNA base, are called single nucleotide polymorphisms (SNPs). However, individual GWA studies often do not have the statistical power to detect subtle but important variants that are ...
... Progression and Therapeutics Interventions in Parkinson's Disease Patrizia Fanara, Ph.D., KineMed, Inc. Selective Inhibition of Cyclic nucleotide Phosphodiesterase Type 7 (PDE7): A Novel and Efficacious Approach to Treating Parkinson's Disease Vincent Allen Florio, Ph.D., Omeros Corporation ...
... of active drug in the liver. We anticipate completing the required animal toxicity studies and filing an IND in the first quarter of 2009." nucleotide analogs have shown the ability to deliver higher levels of the active triphosphate form of the drug into infected cells. PSI-7851 has demonstrated in ...
... in the U.S. and Canada under the Gensona(R) brand and marketed by Alticor Inc. The Gensona(R) Heart Health Genetic Test employs a number of single nucleotide polymorphisms (genetic sequence variations called SNPs) to identify specific genetic patterns in the Interleukin 1 genes. These genetic patterns are ...
... for the Study of the Liver (EASL) being held this week in Milan, Italy. Second-Generation Nucleoside Polymerase Inhibitor Program IDX184 is a nucleotide prodrug derived from Idenix's proprietary liver- targeting technology. Results from in vitro and in vivo preclinical studies confirm that this ...
... to Karmanos Principal Investigator Alison L. Van Dyke, MD/PhD Candidate, Class of 2011. Genetic variation was evaluated by looking at single nucleotide polymorphisms (SNPs) in cytokine genes. Population-based cases included 95 African-American and 365 Caucasian women, aged 18-74. Each had been ...
... to patients as quickly as possible." The procedure, known as "Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," makes it possible for the first time to fully evaluate the genetic make up of human embryos quickly and accurately enough to ...
... DNA in cells, and contains an estimated 700 to 1,100 genes. The region the CGEMS study identified on chromosome 8 is marked by a number of single nucleotide polymorphisms (SNPs), including rs6983267. SNPs are the most common type of gene variant in which a single unit of DNA may vary from one person to ...
... Research Annual Meeting in Los Angeles. The poster presentation is entitled "Cytotoxicity of novel alkylating anthraquinones in cells with DNA nucleotide Excision Repair and DNA Mismatch Repair defects," and focuses on structure-activity studies on the company's novel technology for targeting and ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
... application. IDX184 is a once-daily, oral nucleotide prodrug polymerase inhibitor for the treatment of ... for the treatment of hepatitis C." IDX184 nucleotide Prodrug Polymerase Inhibitor IDX184 is a once-daily, oral nucleotide prodrug candidate based on Idenix's proprietary ...Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
... dose (SAD) study in healthy volunteers with PSI-7851, a second generation nucleotide analog polymerase inhibitor of hepatitis C virus (HCV). Pharmasset filed ... milestone for Pharmasset. PSI-7851 is a wholly owned, second generation nucleotide analog that was discovered by Pharmasset scientists" stated Dr. Michelle ...... that it has initiated a proof-of-concept study of IDX184, a liver-targeted nucleotide prodrug candidate for the treatment of HCV under an Investigational New ... and two to placebo. About IDX184 IDX184 is a once-daily, oral nucleotide prodrug candidate based on Idenix's proprietary liver-targeting ....
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
... drug for a kidney target, ISIS 388626 is also unique due to its 12 nucleotide length rather than the more typical 18 - 21 nucleotide sequences that comprise Isis' other drugs. This attribute simplifies ...Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
... programs, having presented data from preclinical studies of its lead nucleotide prodrug candidate, IDX184, and potential clinical candidates from its ... the EASL presentations.) -- The lead clinical candidate from the nucleotide prodrug program, IDX184, is on track for an investigational new ...... DNA damage measured by histone H2AX phosphorylation independently of the nucleotide excision repair pathways. (Abstract #B77) Yves Pommier, M.D., Ph.D., ... 743. In addition, the study showed brostallicin is less dependent on the nucleotide excision repair (NER) gene than ecteinascidin 743 and that cells selected ...
... 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," provides fertility specialists for the first time ... amplified, approximately 250,000 different areas of the DNA, called single nucleotide polymorphisms (SNPs, or "snips") are individually examined and assigned a ...
... data set from this study at a scientific meeting later this year. About IDX184 IDX184 is a novel, liver-targeted 2'-methyl guanosine nucleotide prodrug, which includes Idenix's proprietary liver-targeting technology. This technology enables the delivery of nucleoside monophosphate to the ...
... a rapid, accurate, and cost efficient manner. SEQUENOM's MassARRAY system facilitates a number of nucleic acid analysis applications including single nucleotide polymorphism (SNP) genotyping and allelotyping, copy number variation analysis, quantitative gene expression analysis, quantitative methylation ...
Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug
... for the in vitro treatment of human and animal sperm, in which the active ingredient is adenosine 5'-triphosphate (ATP). ATP is a ubiquitous purine nucleotide found in every cell of the human body where it plays a critical role in cellular metabolism and constitutes the source of energy for all bodily ...Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
... clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial. ...Creighton Medical Laboratories First to Offer New Cancer Test
... genomics at Creighton Medical Laboratories. "We can detect genetic abnormalities that previously would have been missed." The SNP (single nucleotide polymorphism) array used by Creighton allows the detection of a very common genetic abnormality or lesion in cancer cells - called copy neutral ...TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR
... to improved hot start PCR results. Using CleanAmp(TM) dNTPs allows precise control at the start of PCR thermal cycling by blocking DNA polymerase nucleotide incorporation until heat activated. The temperature dependent control of DNA polymerase extension vastly reduces mis-priming, primer dimer formation ...... of HIV in combination with other approved HIV drugs, has completed a Phase II clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered Phase I studies. Additional information is available on the Internet at http://www.pharmasset.com ...
... of HIV in combination with other approved HIV drugs, has completed a Phase II clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered Phase I studies. Pharmasset Forward-Looking Statements Pharmasset "Safe Harbor" Statement under the Private ...
Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
... treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial. PSI-7851, an unpartnered second generation HCV nucleotide analogue recently entered phase 1 studies. Pegasys(R) and Copegus(R) are registered trademarks of Roche. Contact Richard E. T. ...... found Korean women in the study were seventy percent more likely to get vertebral fracture if they carried a genetic variation, also called single nucleotide polymorphism (SNP), in the IL-10 gene, while those who carried a SNP in the IL1-RN gene were fifty percent more predisposed to vertebral fracture. ...
... and detect the most significant gene variants associated with a given disease. Those variants, each a change in a single DNA base, are called single nucleotide polymorphisms (SNPs). However, individual GWA studies often do not have the statistical power to detect subtle but important variants that are ...
Scientists Unmask Genetic Markers Associated With Psoriasis
... the first time by this study, and two more have since been confirmed by these researchers. Research details The team looked for single nucleotide polymorphisms (SNPs), or DNA changes, at 438,670 sites in 1,359 psoriasis cases and 1,400 healthy controls. Initial scans signaled differences in at ...... Progression and Therapeutics Interventions in Parkinson's Disease Patrizia Fanara, Ph.D., KineMed, Inc. Selective Inhibition of Cyclic nucleotide Phosphodiesterase Type 7 (PDE7): A Novel and Efficacious Approach to Treating Parkinson's Disease Vincent Allen Florio, Ph.D., Omeros Corporation ...
Pharmasset Reports Fiscal Year End 2008 Financial Results
... regimen for HCV, which we believe would be the future of treatment. These efforts provide the groundwork for our next generation of nucleoside and nucleotide inhibitors, such as PSI-7851, that hold the potential for us to explore fixed dosed combinations." Financial Results For the fiscal ...St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse
... diagnosed and after they had relapsed. The investigators used millions of genetic markers -- characteristic genetic variations called single nucleotide polymorphisms -- as guideposts to pinpoint genetic changes characteristic of relapsed cells. Using these genetic markers, the researchers analyzed ...Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
... and 3 treatment-experienced HCV patients. -- Nominated PSI-7851 as a lead product candidate for the treatment of HCV. PSI-7851 is a proprietary nucleotide analogue polymerase inhibitor of HCV that is being advanced into Good Laboratory Practice (GLP) toxicology studies. -- Announced receipt of ...Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
... at the Kleberg Center for Molecular Markers," said Rahul Mitra, Ph.D., associate director of the Kleberg Center. About LNATM LNAs are a class of nucleotide analogues that bind very strongly to RNA and DNA targets. By including LNAs in detection probes, it is possible to design very specific high-affinity ...... of active drug in the liver. We anticipate completing the required animal toxicity studies and filing an IND in the first quarter of 2009." nucleotide analogs have shown the ability to deliver higher levels of the active triphosphate form of the drug into infected cells. PSI-7851 has demonstrated in ...
... in the U.S. and Canada under the Gensona(R) brand and marketed by Alticor Inc. The Gensona(R) Heart Health Genetic Test employs a number of single nucleotide polymorphisms (genetic sequence variations called SNPs) to identify specific genetic patterns in the Interleukin 1 genes. These genetic patterns are ...
... for the Study of the Liver (EASL) being held this week in Milan, Italy. Second-Generation Nucleoside Polymerase Inhibitor Program IDX184 is a nucleotide prodrug derived from Idenix's proprietary liver- targeting technology. Results from in vitro and in vivo preclinical studies confirm that this ...
... to Karmanos Principal Investigator Alison L. Van Dyke, MD/PhD Candidate, Class of 2011. Genetic variation was evaluated by looking at single nucleotide polymorphisms (SNPs) in cytokine genes. Population-based cases included 95 African-American and 365 Caucasian women, aged 18-74. Each had been ...
Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
... Second-Generation Nucleoside Polymerase Inhibitor Program Idenix's preclinical HCV nucleoside polymerase inhibitor program comprises two novel nucleotide prodrugs, IDX184 and IDX102. This program is based on Idenix's proprietary liver-targeting technology, which delivers high levels of nucleoside ...... to patients as quickly as possible." The procedure, known as "Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," makes it possible for the first time to fully evaluate the genetic make up of human embryos quickly and accurately enough to ...
Versatility of 454 Sequencing(TM) Demonstrated in Three Publications in Science Last Week
... reads, including paired reads, characteristic of 454 Sequencing. Previous studies of human genomic variation tended to look at changes called single nucleotide polymorphism (SNP), variations that involve just one nucleotide. However, the study, "Paired-End Mapping Reveals Extensive Genomic Structural ...Major Gene Study Uncovers Secrets of Leukemia
... more than 350,000 markers called single nucleotide polymorphisms. Single nucleotide polymorphisms are individual variations in the DNA that are spaced across the human chromosomes. Single nucleotide polymorphisms function as flags for researchers, allowing them to detect ...Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR
... today announced that the company will present data on a novel nucleotide analog, GS 9219, which has shown evidence of anti-cancer activity in ... in the United States. About GS 9219 GS 9219 is a prodrug of the nucleotide analog PMEG (9-(2-phosphonylmethoxyethyl)guanine). It is selectively ...... DNA in cells, and contains an estimated 700 to 1,100 genes. The region the CGEMS study identified on chromosome 8 is marked by a number of single nucleotide polymorphisms (SNPs), including rs6983267. SNPs are the most common type of gene variant in which a single unit of DNA may vary from one person to ...
... Research Annual Meeting in Los Angeles. The poster presentation is entitled "Cytotoxicity of novel alkylating anthraquinones in cells with DNA nucleotide Excision Repair and DNA Mismatch Repair defects," and focuses on structure-activity studies on the company's novel technology for targeting and ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
... (IOCB) in Prague and Dr. Erik DeClercq, Rega Institute for Medical Research, Katholic University in Leuven, Belgium. About Hepsera Hepsera, a nucleotide analogue for the treatment of chronic hepatitis B, works by inhibiting HBV DNA polymerase, an enzyme involved in the replication of the virus in the ...
Other ContentsdystrophydystrophydystrophydystrophysympatheticsympatheticsympatheticsympatheticsympatheticnephropathynephropathyrefluxrefluxrefluxrefluxregurgitationregurgitationrefractionrelationshipsrelationshipsrelationshipsrelationshipsrelationshipsrelationshipsrelationshipsOther TagsElmElmElm
(Date:12/16/2009)... Knowledge and Innovation Community (Climate-KIC)" is a major initiative ... program brings together the expertise of world class partners ... Europe,s innovation capacity to meet the climate change challenge ... a new low-carbon society. In responding to this challenge, ... produce, distribute, and consume goods, and to how we ...
(Date:12/16/2009)... network of interactions. Today,s techniques, however, can only ... the cells. Since molecular concentrations are much higher ... that the kinetics of molecular reactions in living ... the cellular reaction speed to be higher," confirms ... optical approach showed that depending on the ...
(Date:12/16/2009)... Maryland School of Medicine researcher will lead the coordinating ... scientists in the field of stem cell research. Michael ... was chosen by the National Heart, Lung and Blood ... of national experts, which will be called the NHLBI ... funded by a $30 million grant over seven years. ...
Breaking Biology News(10 mins):Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Looking for the heartbeat of cellular networks 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday October 28 at 5 3A00 p m ET 14295 1BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday October 28 at 5 3A00 p m ET 14295 2Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 1Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 2Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 3A new chemical method for distinguishing between farmed and wild salmon 10178 1A new chemical method for distinguishing between farmed and wild salmon 10178 2(Date:12/16/2009)... New Enterprise Associates, Inc. (NEA), a leading global ... its portfolio companies, Acclarent, Inc., has entered into ... Inc., a Johnson & Johnson company, in an ... estimated cash on hand at time of closing). ... and commercializing devices that address conditions affecting the ...
(Date:12/16/2009)... Blacks, other minorities might not gain full benefit from ... -- Human embryonic stem cell lines currently used for ... finds. , That could mean that non-whites will ... that research down the line, experts say. , Blacks ... most widely used stem cell lines studied showed any ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 Losing has never felt ... knows maintaining his healthy new lifestyle means continuing to ... Drinking fat free milk is one healthy choice that ... a simple step everyone can take. Every glass of ... muscle, potassium to help maintain normal blood pressure, and ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at ... holidays can be a particularly difficult time. Wounded ... than ever on the healing power of connecting with ... got easier for Walter Reed patients as Verizon Wireless ... hundreds of minutes of holiday talk time for 2,500 ...
(Date:12/16/2009)... WASHINGTON, Dec. 16 As a result of ... a new peer reviewed cancer research program is included ... ,, This new cancer research program will research ... the breast, prostate, lung and ovarian cancer research programs ... Command. ,, The $15 million in funding ...
Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:House Creates New Cancer Research Program 2Health News:House Creates New Cancer Research Program 3[0] NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon[0] Most Stem Cells Used in Research Come From Whites[1] 'The Biggest Loser' Champ Lives Well With Milk[0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital[0] House Creates New Cancer Research Program
CockleburMulberrySycamorePrivetMesquiteJuniperMelaleucaShagbarkHickoryEucalyptusElmCottonwoodBirchGroundsel
Other Tagslocals 2mobile 2mobile 3brown 2brown 3frogs 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |